InvestorsHub Logo
Followers 0
Posts 118
Boards Moderated 0
Alias Born 02/24/2014

Re: None

Thursday, 06/30/2022 8:48:21 PM

Thursday, June 30, 2022 8:48:21 PM

Post# of 6314
Wow! Talk about at the buzzer. They hit their Q2 approval goal.
Let's see if we can execute on the timeline for starting the trial + interim data this year, then final data in Q1 next year!

(From their corporate presentation):
SBI-100 OE: PHASE 1
? Q1-22: Completion of GLP toxicology studies
? Q2-22: AUS Human Research Ethics Committee (HREC) approval to start Phase 1 study
? Q3-22: Phase 1 interim data
? Q1-23: Phase 1 final data